ClinicalTrials.govpublic full text
A Phase I Study to Investigate Tolerability and Efficacy of ALECSAT Administered to Glioblastoma Multiforme Patients
glioblastoma multiforme, brain cancer, immunotherapy, cell based therapy, autologous cell based therapy, adoptive immunotherapy, cytotoxic t cells, natural killer cells, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 913739
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.